Health-care companies ticked down amid mixed earnings.
Swiss drug maker Roche said first-quarter sales declined amid weak demand for Covid-19 products and currency headwinds but slightly beat analysts expectations.
Shares of medical-device maker Boston Scientific rose after it forecast growth ahead of Wall Street expectations.
Biogen shares rallied after the biopharmaceutical company reported better-than-expected earnings and a hefty increase in sales of its Alzheimer's drug.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-24-24 1716ET
